Skip to main navigation Our Science AT-527 COVID-19 About Atea Investors Careers Contact INVESTOR RELATIONS Committee Composition Breadcrumb Investors Committee Composition Audit Committee Compensation Committee Nominating and Corporate Governance Committee Strategy and Public Policy Committee Jerome Adams, M.D., M.P.H. Nominating and Corporate Governance Committee Strategy and Public Policy Committee Franklin Berger Audit Committee Compensation Committee Barbara Duncan Audit Committee Nominating and Corporate Governance Committee Bruno Lucidi Audit Committee Compensation Committee Polly A. Murphy, D.V.M., Ph.D. Nominating and Corporate Governance Committee Strategy and Public Policy Committee Bruce Polsky, M.D Compensation Committee Strategy and Public Policy Committee = Chairperson = Member Investor FAQs RSS Feeds Email Alerts Contact IR Atea is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment. Atea Pharmaceuticals, Inc. 125 Summer Street Boston, MA 02110 (857) 284-8891 Copyright © 2021 By Atea Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy | Terms of Use

Our Science AT-527 COVID-19 About Atea Investors Careers Contact The use of nucleoside and nucleotide analogs to inhibit the viral RNA polymerase, thereby preventing propagation of the virus, is a well-documented and historically successful approach to treatment of various viral diseases, including HIV/AIDS, herpesvirus, hepatitis B and hepatitis C infections. Therapies based on our platform. AT-527 is an example of the uniqueness of our platform in discovering highly innovative oral nucleotide therapeutics. This sophisticated double prodrug is synthesized as a specific salt form, which required new breakthroughs in our knowledge of medicinal chemistry and cellular pharmacology. PIPELINES & PROGRAMS Atea is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment. Atea Pharmaceuticals, Inc. 125 Summer Street Boston, MA 02110 (857) 284-8891 Copyright © 2020 By Atea Pharmaceuticals. All Rights Reserved. Privacy Policy | Terms of Use

Skip to main navigation Our Science AT-527 COVID-19 About Atea Investors Careers Contact INVESTOR RELATIONS RSS Feeds Breadcrumb Investors Shareholder Resources RSS Feeds RSS (Really Simple Syndication) feeds provide an easy way to keep up with news and information about our company. Most web browsers have built in RSS readers, or you can use our feeds in an RSS reader or aggregator. Latest News Releases Latest SEC Filings Recent Events Investor FAQs RSS Feeds Email Alerts Contact IR Atea is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment. Atea Pharmaceuticals, Inc. 125 Summer Street Boston, MA 02110 (857) 284-8891 Copyright © 2021 By Atea Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy | Terms of Use